Palo Verde Hematology/ Oncology Center, Ltd. ( Site 0175) — Glendale, Arizona

Palo Verde Hematology/ Oncology Center, Ltd. ( Site 0175) is a clinical research site located in Glendale, Arizona, United States 85304.

Crixeo Clinical Trials Trust Score: 11/100 (FAILING). This profile has not yet been claimed by the site owner.

Palo Verde Hematology/ Oncology Center, Ltd. ( Site 0175) has participated in 2 clinical trials with 2 currently active.

Therapeutic areas: DLBCL, Diffuse Large B-Cell Lymphoma, Essential Thrombocythemia.

Sponsors: Merck Sharp & Dohme LLC.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Glendale

Browse all research sites in Arizona · View every site in Glendale

Sponsor Feasibility Report

Trust Score: 11/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Palo Verde Hematology/ Oncology Center, Ltd. ( Site 0175)?

Palo Verde Hematology/ Oncology Center, Ltd. ( Site 0175) has a Crixeo Trust Score of 11/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Palo Verde Hematology/ Oncology Center, Ltd. ( Site 0175) conducted?

Palo Verde Hematology/ Oncology Center, Ltd. ( Site 0175) has 2 clinical trials on record, with 2 currently active. Their work covers DLBCL, Diffuse Large B-Cell Lymphoma, Essential Thrombocythemia.

Is Palo Verde Hematology/ Oncology Center, Ltd. ( Site 0175) accredited by Crixeo Clinical Trials?

Palo Verde Hematology/ Oncology Center, Ltd. ( Site 0175) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Palo Verde Hematology/ Oncology Center, Ltd. ( Site 0175)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.